A. KAZĞAN KILIÇASLAN Et Al. , "Serum klotho and FGF23 Levels in Patients with Schizophrenia," PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.3, pp.229-236, 2022
KAZĞAN KILIÇASLAN, A. Et Al. 2022. Serum klotho and FGF23 Levels in Patients with Schizophrenia. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.3 , 229-236.
KAZĞAN KILIÇASLAN, A., YILDIZ, S., Emir, B. S., KILIÇ, F., & Atmaca, M., (2022). Serum klotho and FGF23 Levels in Patients with Schizophrenia. PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.3, 229-236.
KAZĞAN KILIÇASLAN, ASLI Et Al. "Serum klotho and FGF23 Levels in Patients with Schizophrenia," PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.3, 229-236, 2022
KAZĞAN KILIÇASLAN, ASLI K. Et Al. "Serum klotho and FGF23 Levels in Patients with Schizophrenia." PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.3, pp.229-236, 2022
KAZĞAN KILIÇASLAN, A. Et Al. (2022) . "Serum klotho and FGF23 Levels in Patients with Schizophrenia." PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY , vol.32, no.3, pp.229-236.
@article{article, author={ASLI KAZĞAN KILIÇASLAN Et Al. }, title={Serum klotho and FGF23 Levels in Patients with Schizophrenia}, journal={PSYCHIATRY AND CLINICAL PSYCHOPHARMACOLOGY}, year=2022, pages={229-236} }